progenerika Logo
progenerika Logo progenerika Logo
shutterstock/279658394

Our Board

The board of Pro Generika consists of seven representatives of important generics companies in Germany.

It is newly elected from among our member companies every two years.

Andreas Burkhardt

chairman

More Information

Andreas Burkhardt

Andreas Burkhardt has been with Teva for 15 years in various management roles. He was appointed General Manager Germany and Austria in November 2021.

@SveaPietschmann

Thomas Weigold

deputy chairman

More Information

Thomas Weigold

Thomas Weigold has been Country President of Sandoz and Spokesman of the Executive Board of Hexal AG in Germany since January 2023. He has worked for the company in various parts of the world since 1999.

@SveaPietschmann

Josip Mestrovic

treasurer

More Information

Josip Mestrovic

Josip Mestrovic has been General Manager at Zentiva Pharma GmbH in Berlin since 2017. With a degree in business administration, he previously worked for Sanofi Germany for six years - most recently as Head of Generics Business.

@SveaPietschmann

Ahmed Banjaddi

board member

More Information

Ahmed Banjaddi

Ahmed Bajaddi has been Head of Generic Business for Germany & Retail Business for Nordics at Basics GmbH & SUN Pharmaceuticals Germany GmbH in Leverkusen since 2017. He has been working for the company since 2008.

Andrej Mieth

board member

More Information

Andrej Mieth

Andrej Mieth has been with Fresenius Kabi since 2001 and has been responsible for various countries and regions. He has been Managing Director of Fresenius Kabi Deutschland GmbH since 2020.

Ingo Werner

board member

More Information

Ingo Werner

Ingo Werner has been working for Mylan Germany, which is part of the Viatris group of companies in Germany, as Head of Public Affairs & Market Access since 2018. In this role, the lawyer is a member of the group's TOP Management Team.

@SveaPietschmann

Basem Yazgi

board member

More Information

Basem Yazgi

Basem Yazgi has been Head of Generics Germany and Vice President at STADA since May 2025. In this role, he is also responsible for managing ALIUD PHARMA as General Manager. He has been with the company since 2013.